World EU seals up to 1.8 billion other BionTech vaccines
Why BionTech Founder Özlem doorCI against the easing of patent protection for vaccines has been proclaimed
since US President Joe Biden, his government supported a patent release of the Corona vaccines, has started the debate internationally to travel. The French President Emmanuel Macron and the EU also signals its openness - but the Federal Government is rejects patent release for vaccines from . Özlem DoorCi, a mit greenery of the German vaccine pioneer Biontech, has also pronounced patent release in an interview with the US news channel CNN.
In the midst of the discussion on the suspension of patents for corona vaccines, the EU has secured up to 1.8 billion other BionTech vaccine doses. EU Commission President Ursula von der Leyen announced the signing of the contract on Saturday on the edge of the EU Social Summit in Portugal. On the advancement of the USA to release patents, EU Heads of State and Government responded. They called on Washington to concretize the proposal.
According to Leyens, with the Mainz company Biiontech and its US partner Pfizer, an agreement has achieved more than 900 million vaccine doses and options to 900 million other vaccines for the years 2021 to 2023. The EU wants to equip himself for refresh vaccinations and against possible future mutations of the virus.
Will Covid-19 vaccines protect you against variants? 9 questions about variants, answered.
How coronavirus variants are affecting vaccines, treatments, and our attempts to return to normal.More than one in three of these new cases were reported in India, the world’s second-most-populous country and now the epicenter of Covid-19. The rising infections, deaths, and strained health system have created a humanitarian crisis, one that may not relent for months.
approved in the EU so far in addition to the Vakzin of Biontech and Pfizer the Corona vaccines of Moderna, AstraZeneca and Johnson & Johnson. At CureVac, Sputnik V and Sanofi GSK, an approval is still out.
, especially at AstraZeneca, had massive delivery delays in recent months. The Corona vaccine of the British Swedish Group was also in recent weeks, especially because of rare heavy side effects. Several countries, including Germany, had temporarily stopped the AstraZeneca vaccinations after cases of blood clots, but after a recommendation of the EU pharmaceutical authority EMA.
In the debate on a suspension of vaccine patents, EU Heads of State and Government avoided a concrete definition. The participants of the summit in Porto are not believed that a release "short-term a miracle solution" was to eliminate the worldwide vaccine shortage, said EU Council President Charles Michel on Saturday. "But we are ready to deal with this topic as soon as a concrete proposal comes to the table".
Covid jab maker BioNTech to build SE Asia manufacturing site
Covid jab maker BioNTech said Monday it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year. Construction of the site will start this year, and it could become operational by 2023, the German company said in a statement. "With this planned mRNA production facility, we will increase our overall network capacity and expand our ability to manufacture and deliver our mRNA vaccines and therapies to people around the world". Construction of the site will start this year, and it could become operational by 2023, the German company said in a statement.
The Government of US President Joe Biden had surprisingly signaled on Wednesday that it wants to support a suspension of patent protection for corona vaccines. This was partially welcomed from the ranks of the EU countries. Already at the prelude of the summit in Porto, however, the skeptical voices multiplied. The Federal Government also rated the push critical.
"We all agree that we have to do everything possible to increase the production of vaccines anywhere in the world," Michel said after the heads of state and government had advised on Friday night. He pointed out that the EU is to export as opposed to other vaccine producers. The EU encourages "all partners" to enable exports.
"Priority do not have patents," said France's President Emmanuel Macron. It's about the question of whether manufacturer's countries are also ready to export. Here it has to give more solidarity. In addition, it deals with the transfer of technology for production, so that more factories dominated the complex manufacturing processes for the vaccines.
The patent question must be discussed, Macron said. This must be "but in a limited manner", as was the case in the release of patents for certain means against AIDS in order to provide them with poorer countries. However, when mental property rights would be "torn", incentives for innovation were lost.
support received the proponents of a suspension of Pope Francis patents' patents. In the Corona Pandemic he wishes a "spirit of justice that mobilizes us to ensure general access to vaccines and temporary suspension of intellectual property rights," said the Catholic church head in a video message on the occasion of the charity concert "Vax Live".
BFI / GT / CHA
USA FOR Suspension of Patents for Corona Vaccines .
More than 100 WTO Member States require vitely to temporarily reduce patent protection for corona vaccines. Now the US government wants to actively support the project. © Abdurrahman Antakyali / Depepo Photos / Abacappress / Picture Alliance Corona vaccine doses of the German-American manufacturer BIONTECH / PFIZER In the fight against the Corona pandemic, the US government has pronounced for a temporary suspension of patent protection for vaccines .